Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 2 (2005), Issue 7 (July)

1. Intensity-modulated radiotherapy technique for three-field breast treatment.
   Int J Radiat Oncol Biol Phys, 62(4): 1217-23. [Abstract] [Full-text]
2. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
   Int J Radiat Oncol Biol Phys, 62(4): 1204-16. [Abstract] [Full-text]
3. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy.
   Int J Radiat Oncol Biol Phys, 62(4): 1195-203. [Abstract] [Full-text]
4. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
   Int J Radiat Oncol Biol Phys, 62(4): 1150-6. [Abstract] [Full-text]
5. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
   Int J Radiat Oncol Biol Phys, 62(4): 1133-9. [Abstract] [Full-text]
6. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
   Int J Radiat Oncol Biol Phys, 62(4): 1125-32. [Abstract] [Full-text]
7. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
   Int J Radiat Oncol Biol Phys, 62(4): 1117-24. [Abstract] [Full-text]
8. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
   Int J Radiat Oncol Biol Phys, 62(4): 1108-16. [Abstract] [Full-text]
9. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
   Int J Radiat Oncol Biol Phys, 62(4): 1055-69. [Abstract] [Full-text]
10. Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysis.
    Int J Radiat Oncol Biol Phys, 62(4): 1021-9. [Abstract] [Full-text]
11. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
    Int J Radiat Oncol Biol Phys, 62(4): 995-1002. [Abstract] [Full-text]
12. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity.
    Int J Radiat Oncol Biol Phys, 62(4): 981-7. [Abstract] [Full-text]
13. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion.
    Int J Radiat Oncol Biol Phys, 62(4): 974-80. [Abstract] [Full-text]
14. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
    Int J Radiat Oncol Biol Phys, 62(4): 956-64. [Abstract] [Full-text]
15. Dosimetric quality assurance for intensity-modulated radiotherapy feasibility study for a filmless approach.
    Strahlenther Onkol, 181(7): 468-74. [Abstract] [Full-text]
16. Radiation exposure of extracranial organs at risk during stereotactic linac radiosurgery.
    Strahlenther Onkol, 181(7): 463-7. [Abstract] [Full-text]
17. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Strahlenther Onkol, 181(7): 448-55. [Abstract] [Full-text]
18. Results of three dimensional conformal radiotherapy and hormonal therapy for local recurrence after radical prostatectomy.
    Strahlenther Onkol, 181(7): 442-7. [Abstract] [Full-text]
19. Patient and personnel dosimetry in endovascular radiotherapy with 90Sr/90Y sources.
    Radiat Prot Dosimetry, 114(4): 514-23. [Abstract] [Full-text]
20. Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer.
    Dis Colon Rectum, 48(7): 1343-9; discussion 1349-52; author reply 1352. [Abstract] [Full-text]
21. Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma?
    Cancer, 104(2): 299-304. [Abstract] [Full-text]
22. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
    Cancer, 104(2): 240-50. [Abstract] [Full-text]
23. Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy.
    Clin Cancer Res, 11(13): 5004s-5010s. [Abstract] [Full-text]
24. Stereotactic radiosurgery, microsurgery, and expectant management of acoustic neuroma: basis for informed consent.
    Otolaryngol Clin North Am, 38(4): 653-70. [Abstract] [Full-text]
25. Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy.
    J Surg Oncol, 91(1): 48-55. [Abstract] [Full-text]
26. Period between completion of radiation therapy and prosthetic rehabilitation in edentulous patients: a retrospective study.
    J Prosthodont, 14(2): 110-21. [Abstract] [Full-text]
27. Stereotactic radiosurgery followed by whole ventricular irradiation for primary intracranial germinoma of the pineal region.
    Minim Invasive Neurosurg, 48(3): 186-90. [Abstract] [Full-text]
28. Gliosarcoma cell death after radiosurgery in a rat model.
    Minim Invasive Neurosurg, 48(3): 142-8. [Abstract] [Full-text]
29. Open radiofrequency ablation for the management of intractable epilepsy associated with sessile hypothalamic hamartoma.
    Minim Invasive Neurosurg, 48(3): 132-5. [Abstract] [Full-text]
30. Determination of dosimetric characteristics of OptiSeed(TM) a plastic brachytherapy (103)Pd source.
    Appl Radiat Isot, 63(3): 311-21. [Abstract] [Full-text]
31. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma.
    J Cosmet Laser Ther, 7(1): 39-43. [Abstract] [Full-text]
32. Factors effecting the Th2-like immune response after gamma-irradiation: low production of IL-12 heterodimer in antigen-presenting cells and small expression of the IL-12 receptor in T cells.
    Int J Radiat Biol, 81(3): 221-31. [Abstract] [Full-text]
33. Two cases of fatal necrosis of the lesser pelvis in patients treated with combined radiotherapy and hyperthermia for cervical carcinoma.
    Int J Hyperthermia, 21(3): 185-92. [Abstract] [Full-text]
34. The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
    Scand J Urol Nephrol, 39(2): 117-23. [Abstract] [Full-text]
35. The first evaluation of brain shift during functional neurosurgery by deformation field analysis.
    J Neurol Neurosurg Psychiatry, 76(8): 1161-3. [Abstract] [Full-text]
36. Long-term complications in survivors of advanced stage neuroblastoma.
    Pediatr Blood Cancer, 45(3): 324-32. [Abstract] [Full-text]
37. Robotically guided radiosurgery for children.
    Pediatr Blood Cancer, 45(3): 304-10. [Abstract] [Full-text]
38. Absolute and relative dose-surface and dose-volume histograms of the bladder: which one is the most representative for the actual treatment?
    Phys Med Biol, 50(15): 3589-97. [Abstract] [Full-text]
39. Limitations of a TCP model incorporating population heterogeneity.
    Phys Med Biol, 50(15): 3571-88. [Abstract] [Full-text]
40. Dosimetric and microdosimetric study of contrast-enhanced radiotherapy with kilovolt x-rays.
    Phys Med Biol, 50(15): 3555-69. [Abstract] [Full-text]
41. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
    Phys Med Biol, 50(15): 3535-54. [Abstract] [Full-text]
42. Intensity modulated radiation therapy for oropharyngeal cancer: the sensitivity of plan objectives and constraints to set-up uncertainty.
    Phys Med Biol, 50(15): 3515-33. [Abstract] [Full-text]
43. A particle swarm optimization algorithm for beam angle selection in intensity-modulated radiotherapy planning.
    Phys Med Biol, 50(15): 3491-514. [Abstract] [Full-text]
44. Effect of image uncertainty on the dosimetry of trigeminal neuralgia irradiation.
    Int J Radiat Oncol Biol Phys, 62(5): 1559-67. [Abstract] [Full-text]
45. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Int J Radiat Oncol Biol Phys, 62(5): 1540-8. [Abstract] [Full-text]
46. Intensity-modulated radiation therapy for mesothelioma: impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency.
    Int J Radiat Oncol Biol Phys, 62(5): 1525-34. [Abstract] [Full-text]
47. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Int J Radiat Oncol Biol Phys, 62(5): 1444-50. [Abstract] [Full-text]
48. Results of stereotactic radiosurgery for patients with imaging defined cavernous sinus meningiomas.
    Int J Radiat Oncol Biol Phys, 62(5): 1427-31. [Abstract] [Full-text]
49. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons.
    Int J Radiat Oncol Biol Phys, 62(5): 1412-22. [Abstract] [Full-text]
50. Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels.
    Int J Radiat Oncol Biol Phys, 62(5): 1385-9. [Abstract] [Full-text]
51. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.
    Int J Radiat Oncol Biol Phys, 62(5): 1379-84. [Abstract] [Full-text]
52. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.
    Int J Radiat Oncol Biol Phys, 62(5): 1371-8. [Abstract] [Full-text]
53. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Int J Radiat Oncol Biol Phys, 62(5): 1283-90. [Abstract] [Full-text]
54. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Jpn J Clin Oncol, 35(7): 375-9. [Abstract] [Full-text]
55. Comparing step-and-shoot IMRT with dynamic helical tomotherapy IMRT plans for head-and-neck cancer.
    Int J Radiat Oncol Biol Phys, 62(5): 1535-9. [Abstract] [Full-text]
56. High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood.
    Cancer, 104(3): 525-31. [Abstract] [Full-text]
57. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma.
    Cancer, 104(3): 580-90. [Abstract] [Full-text]
58. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.
    Cancer Treat Rev, 31(4): 256-73. [Abstract] [Full-text]
59. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
    Strahlenther Onkol, 181(8): 545-50. [Abstract] [Full-text]
60. Ultrafractionation does not improve the results of radiotherapy in radioresistant murine DDL1 lymphoma.
    Strahlenther Onkol, 181(8): 540-4. [Abstract] [Full-text]
61. Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women.
    Strahlenther Onkol, 181(8): 534-9. [Abstract] [Full-text]
62. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
    Strahlenther Onkol, 181(8): 529-33. [Abstract] [Full-text]
63. Positron emission tomography for radiation treatment planning.
    Strahlenther Onkol, 181(8): 483-99. [Abstract] [Full-text]
64. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases.
    J Pain Symptom Manage, 30(1): 18-23. [Abstract] [Full-text]
65. An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device.
    Br J Radiol, 78(932): 737-41. [Abstract] [Full-text]
66. Pantak Therapax SXT 150: performance assessment and dose determination using IAEA TRS-398 protocol.
    Br J Radiol, 78(932): 721-32. [Abstract] [Full-text]
67. Cognitive performance of older women who have survived cancer.
    Int J Neurosci, 115(9): 1307-14. [Abstract] [Full-text]

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.